Institutional investors purchased a net $2.0 million shares of GSK during the quarter ended December 2016 and now own 8.89% of the total shares outstanding. This is a greater percentage than is typical for companies in the Pharmaceuticals: Major industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
CONFLUENCE INVESTMENT MANAGEMENT... Bought 250.3 Thousand shares of GlaxoSmithKline
GW&K INVESTMENT MANAGEMENT LLC Bought 153.6 Thousand shares of GlaxoSmithKline
DYNAMIC ADVISOR SOLUTIONS LLC Bought 89.0 Thousand shares of GlaxoSmithKline